{"id":"NCT00168805","sponsor":"Boehringer Ingelheim","briefTitle":"RE-MODEL Dabigatran Etexilate 150mg or 220mg Once Daily (o.d.) Versus (v.s.) Enoxaparin 40mg o.d. for Prevention of Thrombosis After Knee Surgery","officialTitle":"RE-MODEL (Thromboembolism Prevention After Knee Surgery). Two Different Dose Regimens of Orally Administered Dabigatran Etexilate Capsules [150 or 220 mg Once Daily Starting With a Half Dose (i.e.75 or 110 mg) on the Day of Surgery] Compared to Subcutaneous Enoxaparin 40 mg Once Daily for 6-10 Days","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-11","primaryCompletion":"2006-05","completion":null,"firstPosted":"2005-09-15","resultsPosted":"2010-12-17","lastUpdate":"2014-05-19"},"enrollment":2101,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Arthroplasty, Replacement, Knee","Thromboembolism"],"interventions":[{"type":"DRUG","name":"enoxaparin","otherNames":[]},{"type":"DRUG","name":"dabigatran etexilate","otherNames":[]},{"type":"DRUG","name":"dabigatran etexilate","otherNames":[]}],"arms":[{"label":"dabigatran etexilate 220 mg","type":"EXPERIMENTAL"},{"label":"dabigatran etexilate 150 mg","type":"EXPERIMENTAL"},{"label":"enoxaparin","type":"ACTIVE_COMPARATOR"}],"summary":"A phase III, randomised, parallel-group, double-blind, active controlled study to investigate the ef ficacy and safety of two different dose regimens of orally administered dabigatran etexilate capsule s \\[150 or 220 mg once daily starting with a half dose (i.e.75 or 110 mg) on the day of surgery\\] comp ared to subcutaneous enoxaparin 40 mg once daily for 6 to 10 days, in prevention of venous thromboem bolism in patients with primary elective total knee replacement surgery. RE-MODEL (Thromboembolism prevention after knee surgery)","primaryOutcome":{"measure":"Number of Participants With Total Venous Thromboembolic Event and All-cause Mortality During Treatment Period","timeFrame":"First administration until 6-10 days","effectByArm":[{"arm":"Dabigatran 220mg","deltaMin":183,"sd":null},{"arm":"Dabigatran 150mg","deltaMin":213,"sd":null},{"arm":"Enoxaparin","deltaMin":193,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"0.6648"},{"comp":"OG001 vs OG002","p":"0.3553"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":105,"countries":["Australia","Austria","Belgium","Czechia","Denmark","Finland","France","Germany","Hungary","Italy","Netherlands","Poland","South Africa","Spain","Sweden"]},"refs":{"pmids":["22995531","22709460"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":31,"n":679},"commonTop":["Nausea","Vomiting","Deep vein thrombosis","Constipation","Insomnia"]}}